Eradication of Helicobacter pylori is associated with increased exposure to delavirdine in hypochlorhydric HIV-positive patients [3]

Journal of Acquired Immune Deficiency Syndromes

Volumn 24, Issue 1, 2000, Pages 79-82

  Shelton, Mark J ^a   Akbari, Bardia ^b   Hewitt, Ross G ^a   Adams, John M ^c   Morse, Gene D ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b HOFFMANN LA ROCHE INC   (United States)

^c PharmaResearch Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; BISMUTH SALICYLATE; CYTOCHROME P450 3A4; DELAVIRDINE; DIDANOSINE; METRONIDAZOLE; PROTON PUMP INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TETRACYCLINE;

ACHLORHYDRIA; ADULT; ANTIBIOTIC THERAPY; AREA UNDER THE CURVE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG EXPOSURE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MALE; PRIORITY JOURNAL; STOMACH PH; TREATMENT OUTCOME;

EID: 0034190732     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200005010-00015     Document Type: Letter

References (27)